This work is licensed under the Creative Commons Attribution 4.0 International License.
Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476-86.PotterBKBurnsTCLacapAPGranvilleRRGajewskiDAHeterotopic ossification following traumatic and combat-related amputations2007894768610.2106/JBJS.F.0041217332095Search in Google Scholar
Sanchez-Duffhues G, Hiepen C, Knaus P, Ten Dijke P. Bone morphogenetic protein signalling in bone homeostasis. Bone 2015;80:43-59.Sanchez-DuffhuesGHiepenCKnausPTenDijke PBone morphogenetic protein signalling in bone homeostasis201580435910.1016/j.bone.2015.05.02526051467Search in Google Scholar
Grafe I, Alexander S, Peterson JR, et al. TGF-beta Family Signaling in Mesenchymal Differentiation. Cold Spring Harb Perspect Biol. 2018;10: a022202.GrafeIAlexanderSPetersonJRet alTGF-beta Family Signaling in Mesenchymal Differentiation201810a02220210.1101/cshperspect.a022202593259028507020Search in Google Scholar
Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009;18:545-59.KangQSongWXLuoQet alA comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells2009185455910.1089/scd.2008.0130313295018616389Search in Google Scholar
Luu HH, Song WX, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007;25:665-77.LuuHHSongWXLuoXet alDistinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells2007256657710.1002/jor.2035917290432Search in Google Scholar
Wang YK, Sun WF, Liu XG, et al. Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients. Zhongguo Gu Shang. 2011;24:399-403.WangYKSunWFLiuXGet alComparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients201124399403Search in Google Scholar
Kang H, Dang AB, Joshi SK, et al. Novel mouse model of spinal cord injury-induced heterotopic ossification. J Rehabil Res Dev. 2014;51:1109-18.KangHDangABJoshiSKet alNovel mouse model of spinal cord injury-induced heterotopic ossification20145111091810.1682/JRRD.2014.01.001925436890Search in Google Scholar
Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004;292:490-5.HofbauerLCSchoppetMClinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases2004292490510.1001/jama.292.4.49015280347Search in Google Scholar
Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modelling and remodelling. Arch Biochem Biophys. 2008;473:139-46.BoyceBFXingLFunctions of RANKL/RANK/OPG in bone modelling and remodelling20084731394610.1016/j.abb.2008.03.018241341818395508Search in Google Scholar
Boyce BF, Xing L, Shakespeare W, et al. Regulation of bone remodelling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases. Kidney Int Suppl. 2003:S2-5.BoyceBFXingLShakespeareWet alRegulation of bone remodelling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases2003S2–510.1046/j.1523-1755.63.s85.2.x12753255Search in Google Scholar
Sherman AL, Williams J, Patrick L, Banovac K. The value of serum creatine kinase in early diagnosis of heterotopic ossification. J Spinal Cord Med. 2003;26:227-30.ShermanALWilliamsJPatrickLBanovacKThe value of serum creatine kinase in early diagnosis of heterotopic ossification2003262273010.1080/10790268.2003.1175368814997963Search in Google Scholar
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10.SingerMDeutschmanCSSeymourCWet alThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)20163158011010.1001/jama.2016.0287Search in Google Scholar
Argyropoulou MI, Kostandi E, Kosta P, et al. Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging. Crit Care, 2006;10:R152.ArgyropoulouMIKostandiEKostaPet alHeterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging200610R15210.1186/cc5083Search in Google Scholar
Yano M, Kawao N, Okumoto K, Tamura Y, Okada K, Kaji H. Fibrodysplasia ossificans progressiva-related activated activin-like kinase signalling enhances osteoclast formation during heterotopic ossification in muscle tissues. J Biol Chem. 2014;289:16966-77.YanoMKawaoNOkumotoKTamuraYOkadaKKajiHFibrodysplasia ossificans progressiva-related activated activin-like kinase signalling enhances osteoclast formation during heterotopic ossification in muscle tissues2014289169667710.1074/jbc.M113.526038Search in Google Scholar
Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009;91:652-63.LounevVYRamachandranRWosczynaMNYamamotoMMaidmentADShoreEMet alIdentification of progenitor cells that contribute to heterotopic skeletogenesis2009916526310.2106/JBJS.H.01177Search in Google Scholar
Scott MA, Levi B, Askarinam A, et al. Brief review of models of ectopic bone formation. Stem Cells Dev. 2012;21:655-67.ScottMALeviBAskarinamAet alBrief review of models of ectopic bone formation2012216556710.1089/scd.2011.0517Search in Google Scholar
Tanaka H, Nagai E, Murata H, et al. Involvement of bone morphogenic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament. Rheumatology 2001;40:1163-8.TanakaHNagaiEMurataHet alInvolvement of bone morphogenic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament2001401163810.1093/rheumatology/40.10.1163Search in Google Scholar
Suzuki T, Bessho K, Segami N, Nojima T, Iizuka T. Bone morphogenetic protein-2 in temporomandibular joints with internal derangement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:670-3.SuzukiTBesshoKSegamiNNojimaTIizukaTBone morphogenetic protein-2 in temporomandibular joints with internal derangement199988670310.1016/S1079-2104(99)70007-7Search in Google Scholar
Zhou N, Li Q, Lin X, et al. BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. Cell Tissue Res. 2016;366:101-11.ZhouNLiQLinXet alBMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells20163661011110.1007/s00441-016-2403-027083447Search in Google Scholar
Qu X, Chen Z, Fan D, Xiang S, Sun C, Zeng Y, et al. Two novel BMP-2 variants identified in patients with thoracic ossification of the ligamentum flavum. Eur J Hum Genet 2017;25:565-571.QuXChenZFanDXiangSSunCZengYet alTwo novel BMP-2 variants identified in patients with thoracic ossification of the ligamentum flavum20172556557110.1038/ejhg.2017.2543790728145426Search in Google Scholar
Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008;14:1363-9.YuPBDengDYLaiCSet alBMP type I receptor inhibition reduces heterotopic [corrected] ossification2008141363910.1038/nm.1888284645819029982Search in Google Scholar
Micha D, Voermans E, Eekhoff MEW, et al. Inhibition of TGFbeta signalling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease. Bone 2016;84:169-180.MichaDVoermansEEekhoffMEWet alInhibition of TGFbeta signalling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease20168416918010.1016/j.bone.2016.01.004Search in Google Scholar
Agarwal S, Loder SJ, Breuler C, et al. Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification. Mol Ther. 2017;25:1974-1987.AgarwalSLoderSJBreulerCet alStrategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification2017251974198710.1016/j.ymthe.2017.01.008Search in Google Scholar
Wu J, Ren B, Shi F, Hua P, Lin H. BMP and mTOR signalling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities? J Cell Biochem. 2019;120:12108-12122.WuJRenBShiFHuaPLinHBMP and mTOR signalling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?2019120121081212210.1002/jcb.28710Search in Google Scholar
Al-Fakhri N, Hofbauer LC, Preissner KT, Franke FE, Schoppet M. Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification. Thromb Haemost. 2005;94:1335-7.Al-FakhriNHofbauerLCPreissnerKTFrankeFESchoppetMExpression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification2005941335710.1160/TH05-06-1335Search in Google Scholar
Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12(9):1260-8.BucayNSarosiIDunstanCRet alOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification19981291260810.1101/gad.12.9.1260Search in Google Scholar
Wilkinson JM, Stockley I, Hamer AJ, Barrington NA, Eastell R. Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J Orthop Res. 2003;21:529-34.WilkinsonJMStockleyIHamerAJBarringtonNAEastellRBiochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty2003215293410.1016/S0736-0266(02)00236-XSearch in Google Scholar
Hudson SJ, Brett SJ. Heterotopic ossification--a long-term consequence of prolonged immobility. Crit Care, 2006;10:174.HudsonSJBrettSJHeterotopic ossification--a long-term consequence of prolonged immobility20061017410.1186/cc5091Search in Google Scholar
Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5:908-923.EastellRSzulcPUse of bone turnover markers in postmenopausal osteoporosis2017590892310.1016/S2213-8587(17)30184-5Search in Google Scholar
Fatayerji D, Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res. 1999;14:1203-10.FatayerjiDEastellRAge-related changes in bone turnover in men19991412031010.1359/jbmr.1999.14.7.120310404022Search in Google Scholar